Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant
Journal of Cystic Fibrosis · 2024
DOI: 10.1016/j.jcf.2023.11.004 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cystic Fibrosis, 2024. Verfasst von Diana Coman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Cystic Fibrosis, Benzodioxoles, Liver Transplantation, Indoles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
- Respirology Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
Zitieren
APA
Coman, D., Vincent, C., Huard, G., Marleau, D., Lavoie, A., & Hercun, J. (2024). Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.11.004
Vancouver
Coman D, Vincent C, Huard G, Marleau D, Lavoie A, Hercun J. Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant. Journal of Cystic Fibrosis. 2024. doi:10.1016/j.jcf.2023.11.004
BibTeX
@article{Coman2024,
author = {Coman, Diana and Vincent, Catherine and Huard, Genevieve and Marleau, Denis and Lavoie, Annick and Hercun, Julian},
title = {Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant},
journal = {Journal of Cystic Fibrosis},
year = {2024},
doi = {10.1016/j.jcf.2023.11.004}
}
EUVIMED